Contraceptives Industry Research Report 2024
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
According to APO Research, the global Contraceptives market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.
The report will help the Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Contraceptives market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.
The report will help the Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Contraceptives Market Size (2019-2030) & (US$ Million)
2.2.2 Global Contraceptives Sales (2019-2030)
2.2.3 Global Contraceptives Market Average Price (2019-2030)
2.3 Contraceptives by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Pills
2.3.3 Injectable
2.3.4 Condoms
2.3.5 Vaginal Rings
2.3.6 IUDs
2.3.7 Subdermal Implants
2.3.8 Others
2.4 Contraceptives by End User
2.4.1 Market Value Comparison by End User (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 15–24 years
2.4.3 25–34 years
2.4.4 35–44 years
2.4.5 Above 44 years
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Contraceptives Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Contraceptives Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Contraceptives Revenue of Manufacturers (2019-2024)
3.4 Global Contraceptives Average Price by Manufacturers (2019-2024)
3.5 Global Contraceptives Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Contraceptives, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Contraceptives, Product Type & Application
3.8 Global Manufacturers of Contraceptives, Date of Enter into This Industry
3.9 Global Contraceptives Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Bayer AG
4.1.1 Bayer AG Company Information
4.1.2 Bayer AG Business Overview
4.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Bayer AG Contraceptives Product Portfolio
4.1.5 Bayer AG Recent Developments
4.2 Pfizer, Inc
4.2.1 Pfizer, Inc Company Information
4.2.2 Pfizer, Inc Business Overview
4.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Pfizer, Inc Contraceptives Product Portfolio
4.2.5 Pfizer, Inc Recent Developments
4.3 Teva Pharmaceutical Industries Ltd
4.3.1 Teva Pharmaceutical Industries Ltd Company Information
4.3.2 Teva Pharmaceutical Industries Ltd Business Overview
4.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
4.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
4.4 Merck & Co., Inc
4.4.1 Merck & Co., Inc Company Information
4.4.2 Merck & Co., Inc Business Overview
4.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Merck & Co., Inc Contraceptives Product Portfolio
4.4.5 Merck & Co., Inc Recent Developments
4.5 Actavis, Inc.
4.5.1 Actavis, Inc. Company Information
4.5.2 Actavis, Inc. Business Overview
4.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Actavis, Inc. Contraceptives Product Portfolio
4.5.5 Actavis, Inc. Recent Developments
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Company Information
4.6.2 Johnson & Johnson Business Overview
4.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Johnson & Johnson Contraceptives Product Portfolio
4.6.5 Johnson & Johnson Recent Developments
4.7 Gedeon Richter
4.7.1 Gedeon Richter Company Information
4.7.2 Gedeon Richter Business Overview
4.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Gedeon Richter Contraceptives Product Portfolio
4.7.5 Gedeon Richter Recent Developments
4.8 Novo Nordisk A/S
4.8.1 Novo Nordisk A/S Company Information
4.8.2 Novo Nordisk A/S Business Overview
4.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
4.8.5 Novo Nordisk A/S Recent Developments
4.9 ZiZhu
4.9.1 ZiZhu Company Information
4.9.2 ZiZhu Business Overview
4.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ZiZhu Contraceptives Product Portfolio
4.9.5 ZiZhu Recent Developments
4.10 Baijingyu
4.10.1 Baijingyu Company Information
4.10.2 Baijingyu Business Overview
4.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Baijingyu Contraceptives Product Portfolio
4.10.5 Baijingyu Recent Developments
4.11 Huazhong
4.11.1 Huazhong Company Information
4.11.2 Huazhong Business Overview
4.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Huazhong Contraceptives Product Portfolio
4.11.5 Huazhong Recent Developments
4.12 Sine
4.12.1 Sine Company Information
4.12.2 Sine Business Overview
4.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Sine Contraceptives Product Portfolio
4.12.5 Sine Recent Developments
4.13 Reckitt
4.13.1 Reckitt Company Information
4.13.2 Reckitt Business Overview
4.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Reckitt Contraceptives Product Portfolio
4.13.5 Reckitt Recent Developments
4.14 AbbVie
4.14.1 AbbVie Company Information
4.14.2 AbbVie Business Overview
4.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.14.4 AbbVie Contraceptives Product Portfolio
4.14.5 AbbVie Recent Developments
4.15 Church & Dwight
4.15.1 Church & Dwight Company Information
4.15.2 Church & Dwight Business Overview
4.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Church & Dwight Contraceptives Product Portfolio
4.15.5 Church & Dwight Recent Developments
4.16 The Cooper Companies
4.16.1 The Cooper Companies Company Information
4.16.2 The Cooper Companies Business Overview
4.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.16.4 The Cooper Companies Contraceptives Product Portfolio
4.16.5 The Cooper Companies Recent Developments
4.17 TherapeuticsMD
4.17.1 TherapeuticsMD Company Information
4.17.2 TherapeuticsMD Business Overview
4.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.17.4 TherapeuticsMD Contraceptives Product Portfolio
4.17.5 TherapeuticsMD Recent Developments
4.18 Afaxys
4.18.1 Afaxys Company Information
4.18.2 Afaxys Business Overview
4.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Afaxys Contraceptives Product Portfolio
4.18.5 Afaxys Recent Developments
4.19 Mithra Pharmaceuticals
4.19.1 Mithra Pharmaceuticals Company Information
4.19.2 Mithra Pharmaceuticals Business Overview
4.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
4.19.5 Mithra Pharmaceuticals Recent Developments
5 GLOBAL CONTRACEPTIVES MARKET SCENARIO BY REGION
5.1 Global Contraceptives Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Contraceptives Sales by Region: 2019-2030
5.2.1 Global Contraceptives Sales by Region: 2019-2024
5.2.2 Global Contraceptives Sales by Region: 2025-2030
5.3 Global Contraceptives Revenue by Region: 2019-2030
5.3.1 Global Contraceptives Revenue by Region: 2019-2024
5.3.2 Global Contraceptives Revenue by Region: 2025-2030
5.4 North America Contraceptives Market Facts & Figures by Country
5.4.1 North America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Contraceptives Sales by Country (2019-2030)
5.4.3 North America Contraceptives Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Contraceptives Market Facts & Figures by Country
5.5.1 Europe Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Contraceptives Sales by Country (2019-2030)
5.5.3 Europe Contraceptives Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Contraceptives Market Facts & Figures by Country
5.6.1 Asia Pacific Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Contraceptives Sales by Country (2019-2030)
5.6.3 Asia Pacific Contraceptives Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Contraceptives Market Facts & Figures by Country
5.7.1 Latin America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Contraceptives Sales by Country (2019-2030)
5.7.3 Latin America Contraceptives Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
5.8.1 Middle East and Africa Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Contraceptives Sales by Country (2019-2030)
5.8.3 Middle East and Africa Contraceptives Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Contraceptives Sales by Type (2019-2030)
6.1.1 Global Contraceptives Sales by Type (2019-2030) & (M Units)
6.1.2 Global Contraceptives Sales Market Share by Type (2019-2030)
6.2 Global Contraceptives Revenue by Type (2019-2030)
6.2.1 Global Contraceptives Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Contraceptives Revenue Market Share by Type (2019-2030)
6.3 Global Contraceptives Price by Type (2019-2030)
7 SEGMENT BY END USER
7.1 Global Contraceptives Sales by End User (2019-2030)
7.1.1 Global Contraceptives Sales by End User (2019-2030) & (M Units)
7.1.2 Global Contraceptives Sales Market Share by End User (2019-2030)
7.2 Global Contraceptives Revenue by End User (2019-2030)
7.2.1 Global Contraceptives Sales by End User (2019-2030) & (US$ Million)
7.2.2 Global Contraceptives Revenue Market Share by End User (2019-2030)
7.3 Global Contraceptives Price by End User (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Contraceptives Value Chain Analysis
8.1.1 Contraceptives Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Contraceptives Production Mode & Process
8.2 Contraceptives Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Contraceptives Distributors
8.2.3 Contraceptives Customers
9 GLOBAL CONTRACEPTIVES ANALYZING MARKET DYNAMICS
9.1 Contraceptives Industry Trends
9.2 Contraceptives Industry Drivers
9.3 Contraceptives Industry Opportunities and Challenges
9.4 Contraceptives Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Contraceptives Market Size (2019-2030) & (US$ Million)
2.2.2 Global Contraceptives Sales (2019-2030)
2.2.3 Global Contraceptives Market Average Price (2019-2030)
2.3 Contraceptives by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Pills
2.3.3 Injectable
2.3.4 Condoms
2.3.5 Vaginal Rings
2.3.6 IUDs
2.3.7 Subdermal Implants
2.3.8 Others
2.4 Contraceptives by End User
2.4.1 Market Value Comparison by End User (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 15–24 years
2.4.3 25–34 years
2.4.4 35–44 years
2.4.5 Above 44 years
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Contraceptives Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Contraceptives Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Contraceptives Revenue of Manufacturers (2019-2024)
3.4 Global Contraceptives Average Price by Manufacturers (2019-2024)
3.5 Global Contraceptives Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Contraceptives, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Contraceptives, Product Type & Application
3.8 Global Manufacturers of Contraceptives, Date of Enter into This Industry
3.9 Global Contraceptives Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Bayer AG
4.1.1 Bayer AG Company Information
4.1.2 Bayer AG Business Overview
4.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Bayer AG Contraceptives Product Portfolio
4.1.5 Bayer AG Recent Developments
4.2 Pfizer, Inc
4.2.1 Pfizer, Inc Company Information
4.2.2 Pfizer, Inc Business Overview
4.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Pfizer, Inc Contraceptives Product Portfolio
4.2.5 Pfizer, Inc Recent Developments
4.3 Teva Pharmaceutical Industries Ltd
4.3.1 Teva Pharmaceutical Industries Ltd Company Information
4.3.2 Teva Pharmaceutical Industries Ltd Business Overview
4.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
4.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
4.4 Merck & Co., Inc
4.4.1 Merck & Co., Inc Company Information
4.4.2 Merck & Co., Inc Business Overview
4.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Merck & Co., Inc Contraceptives Product Portfolio
4.4.5 Merck & Co., Inc Recent Developments
4.5 Actavis, Inc.
4.5.1 Actavis, Inc. Company Information
4.5.2 Actavis, Inc. Business Overview
4.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Actavis, Inc. Contraceptives Product Portfolio
4.5.5 Actavis, Inc. Recent Developments
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Company Information
4.6.2 Johnson & Johnson Business Overview
4.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Johnson & Johnson Contraceptives Product Portfolio
4.6.5 Johnson & Johnson Recent Developments
4.7 Gedeon Richter
4.7.1 Gedeon Richter Company Information
4.7.2 Gedeon Richter Business Overview
4.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Gedeon Richter Contraceptives Product Portfolio
4.7.5 Gedeon Richter Recent Developments
4.8 Novo Nordisk A/S
4.8.1 Novo Nordisk A/S Company Information
4.8.2 Novo Nordisk A/S Business Overview
4.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
4.8.5 Novo Nordisk A/S Recent Developments
4.9 ZiZhu
4.9.1 ZiZhu Company Information
4.9.2 ZiZhu Business Overview
4.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ZiZhu Contraceptives Product Portfolio
4.9.5 ZiZhu Recent Developments
4.10 Baijingyu
4.10.1 Baijingyu Company Information
4.10.2 Baijingyu Business Overview
4.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Baijingyu Contraceptives Product Portfolio
4.10.5 Baijingyu Recent Developments
4.11 Huazhong
4.11.1 Huazhong Company Information
4.11.2 Huazhong Business Overview
4.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Huazhong Contraceptives Product Portfolio
4.11.5 Huazhong Recent Developments
4.12 Sine
4.12.1 Sine Company Information
4.12.2 Sine Business Overview
4.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Sine Contraceptives Product Portfolio
4.12.5 Sine Recent Developments
4.13 Reckitt
4.13.1 Reckitt Company Information
4.13.2 Reckitt Business Overview
4.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Reckitt Contraceptives Product Portfolio
4.13.5 Reckitt Recent Developments
4.14 AbbVie
4.14.1 AbbVie Company Information
4.14.2 AbbVie Business Overview
4.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.14.4 AbbVie Contraceptives Product Portfolio
4.14.5 AbbVie Recent Developments
4.15 Church & Dwight
4.15.1 Church & Dwight Company Information
4.15.2 Church & Dwight Business Overview
4.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Church & Dwight Contraceptives Product Portfolio
4.15.5 Church & Dwight Recent Developments
4.16 The Cooper Companies
4.16.1 The Cooper Companies Company Information
4.16.2 The Cooper Companies Business Overview
4.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.16.4 The Cooper Companies Contraceptives Product Portfolio
4.16.5 The Cooper Companies Recent Developments
4.17 TherapeuticsMD
4.17.1 TherapeuticsMD Company Information
4.17.2 TherapeuticsMD Business Overview
4.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.17.4 TherapeuticsMD Contraceptives Product Portfolio
4.17.5 TherapeuticsMD Recent Developments
4.18 Afaxys
4.18.1 Afaxys Company Information
4.18.2 Afaxys Business Overview
4.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Afaxys Contraceptives Product Portfolio
4.18.5 Afaxys Recent Developments
4.19 Mithra Pharmaceuticals
4.19.1 Mithra Pharmaceuticals Company Information
4.19.2 Mithra Pharmaceuticals Business Overview
4.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
4.19.5 Mithra Pharmaceuticals Recent Developments
5 GLOBAL CONTRACEPTIVES MARKET SCENARIO BY REGION
5.1 Global Contraceptives Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Contraceptives Sales by Region: 2019-2030
5.2.1 Global Contraceptives Sales by Region: 2019-2024
5.2.2 Global Contraceptives Sales by Region: 2025-2030
5.3 Global Contraceptives Revenue by Region: 2019-2030
5.3.1 Global Contraceptives Revenue by Region: 2019-2024
5.3.2 Global Contraceptives Revenue by Region: 2025-2030
5.4 North America Contraceptives Market Facts & Figures by Country
5.4.1 North America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Contraceptives Sales by Country (2019-2030)
5.4.3 North America Contraceptives Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Contraceptives Market Facts & Figures by Country
5.5.1 Europe Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Contraceptives Sales by Country (2019-2030)
5.5.3 Europe Contraceptives Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Contraceptives Market Facts & Figures by Country
5.6.1 Asia Pacific Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Contraceptives Sales by Country (2019-2030)
5.6.3 Asia Pacific Contraceptives Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Contraceptives Market Facts & Figures by Country
5.7.1 Latin America Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Contraceptives Sales by Country (2019-2030)
5.7.3 Latin America Contraceptives Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
5.8.1 Middle East and Africa Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Contraceptives Sales by Country (2019-2030)
5.8.3 Middle East and Africa Contraceptives Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Contraceptives Sales by Type (2019-2030)
6.1.1 Global Contraceptives Sales by Type (2019-2030) & (M Units)
6.1.2 Global Contraceptives Sales Market Share by Type (2019-2030)
6.2 Global Contraceptives Revenue by Type (2019-2030)
6.2.1 Global Contraceptives Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Contraceptives Revenue Market Share by Type (2019-2030)
6.3 Global Contraceptives Price by Type (2019-2030)
7 SEGMENT BY END USER
7.1 Global Contraceptives Sales by End User (2019-2030)
7.1.1 Global Contraceptives Sales by End User (2019-2030) & (M Units)
7.1.2 Global Contraceptives Sales Market Share by End User (2019-2030)
7.2 Global Contraceptives Revenue by End User (2019-2030)
7.2.1 Global Contraceptives Sales by End User (2019-2030) & (US$ Million)
7.2.2 Global Contraceptives Revenue Market Share by End User (2019-2030)
7.3 Global Contraceptives Price by End User (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Contraceptives Value Chain Analysis
8.1.1 Contraceptives Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Contraceptives Production Mode & Process
8.2 Contraceptives Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Contraceptives Distributors
8.2.3 Contraceptives Customers
9 GLOBAL CONTRACEPTIVES ANALYZING MARKET DYNAMICS
9.1 Contraceptives Industry Trends
9.2 Contraceptives Industry Drivers
9.3 Contraceptives Industry Opportunities and Challenges
9.4 Contraceptives Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
